2024 forecast: Digital therapeutics makers will have to get creative to conquer reimbursement issues

Fierce Biotech December 22, 2023
Andrea Park

The science behind digital therapeutics may sound dubious on paper—a smartphone app that can help someone quit smoking, reverse Type 2 diabetes or treat depression?

In practice, however, these apps have held their own: Studies show that digital therapeutics from Better Therapeutics and Fitterfly can each significantly reduce blood sugar levels in people with Type 2 diabetes; video game-based technology developed by Akili can improve symptoms of ADHD, lupus and depression; and a virtual reality program from Luminopia could help treat lazy eye in kids.

In recent years, those promising study results have led to FDA approvals and clearances of the virtual technologies. Those commercial green lights, however, have largely failed to translate into profitability for makers of digital therapeutics,...

Today's Sponsors

Today's Sponsor